Safety and tolerability of a 90‐minute rapid infusion of Sandoz biosimilar rituximab in B‐cell lymphoproliferative disorders in a real‐world setting. - Muntañola, Ana; Arguiñano‐Pérez, José María; Dávila, Julio; de Villambrosia, Sonia González; Carpio, Cecilia; Jiménez‐Ubieto, Ana; Salar, Antonio (CTS: Clinical & Translational Science, 2023)